LONDON – The European Commission (EU) is pulling the plug on implementation of the Medical Devices Directive (MDR) on May 26, to free up resources and expertise as countries across Europe struggle to deal with the COVID-19 crisis.
BOGOTA, Colombia – The global shortage of ventilators caused by COVID-19 is not news to the Latin American region, an area already preparing for the tsunami of patients that could flood hospitals as it has done elsewhere. The region is trying to learn from the mistakes made by European countries before it is too late.
The five-day Bio-Europe Spring 2020 conference, possibly the first ever life sciences partnering event staged in an all-virtual format, ended on Friday, March 27, with high hopes that the industry would return to face-to-face interactions next year in Barcelona.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anpac Bio, Astrotech, CDISC, Cohealo, Core Mobile, Cynergistek, Dawex, Deltatrak, Forward Science, Nanovibronix, Nexstim, Phunware, Pieces Technologies, Seek Thermal, Smiledirectclub, Well Health Technologies.
Biopharma industry leaders in China who were the first to experience the chaos of the COVID-19 pandemic shared their thoughts during a closing plenary session of the virtual Bio-Europe Spring 2020 meeting.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avexis, BMS, Cstone, Cytodyn, Eisai, Genentech, Humanigen, Intelgenx, Lupin, Mylan, Novartis, Pharming, Rockwell, Sanofi, Translate Bio.